• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Hepatic oncology. >Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma
【24h】

Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma

机译：当前肝癌治疗指南的比较分析

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Hepatocellular carcinoma is one of the most common malignancies and represents a unique challenge for physicians and patients. Treatment patterns are not uniform between areas despite efforts to promote a common protocol. Even if most hepatologists worldwide adopt the Barcelona Clinic Liver Cancer staging system, Asian and North American physicians are also independently making an effort to expand the indications of each treatment, combining therapies for better outcomes. Also, new therapeutic techniques have emerged and an increasing number of studies are trying to include these paradigm shifts into newer treatment guidelines. Controversial and diverging points in the current international guidelines are emphasized and discussed. Unanswered questions are also analyzed to identify the most needed and promising future perspectives.
机译：肝细胞癌是最常见的恶性肿瘤之一，对医生和患者构成了独特的挑战。尽管努力促进共同的治疗方案，但各地区之间的治疗方式并不统一。即使全世界大多数肝病医生采用巴塞罗那临床肝癌分期系统，亚洲和北美医生也都在独立努力扩大每种治疗的适应症，将疗法结合起来以获得更好的结果。同样，新的治疗技术已经出现，越来越多的研究试图将这些范式转变纳入新的治疗指南。强调和讨论了当前国际准则中有争议的观点。还对未回答的问题进行分析，以确定最需要和最有前途的未来观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号